Dr Binh To Tran, MD | |
612 W Duarte Rd, Arcadia, CA 91007 | |
(626) 821-8124 | |
Not Available |
Full Name | Dr Binh To Tran |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 25 Years |
Location | 612 W Duarte Rd, Arcadia, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922207372 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | A79716 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Huntington Memorial Hospital | Pasadena, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Hill Medical Corporation | 2062301518 | 4 |
The Huntington Medical Foundation | 4587631601 | 72 |
Radiant Imaging Inc | 7113145558 | 55 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Beverly Radiology Medical Group Iii |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20040202001145 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Kern Radiology Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700821972 PECOS PAC ID: 7214826460 Enrollment ID: O20040315000421 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Diagnostic Radiological Imaging |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710931910 PECOS PAC ID: 4981680220 Enrollment ID: O20040626000471 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | The Hill Medical Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154310415 PECOS PAC ID: 2062301518 Enrollment ID: O20040917000570 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | The Huntington Medical Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154467181 PECOS PAC ID: 4587631601 Enrollment ID: O20040923000968 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Truxtun Radiology Medical Group Lp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548265036 PECOS PAC ID: 5698714582 Enrollment ID: O20050429000546 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Pronet Imaging Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528099488 PECOS PAC ID: 5890722755 Enrollment ID: O20050721000831 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Beverly Radiology Medical Group Iii |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20060221000914 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Vallejo Open Mri Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164478277 PECOS PAC ID: 9133132046 Enrollment ID: O20060719000128 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Stockton Diagnostic Imaging |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356538201 PECOS PAC ID: 0749386894 Enrollment ID: O20070507000122 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | San Fernando Valley Interventional Radiology And Imaging Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942350889 PECOS PAC ID: 3476651431 Enrollment ID: O20070614000478 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Fresno Imaging Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659456499 PECOS PAC ID: 2466553128 Enrollment ID: O20070724000813 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Norcal Imaging |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003965997 PECOS PAC ID: 7911099346 Enrollment ID: O20070815000403 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Radnet Medical Imaging - San Francisco |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548345382 PECOS PAC ID: 9830283761 Enrollment ID: O20070921000636 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Emeryville Advanced Imaging Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376597930 PECOS PAC ID: 3375637051 Enrollment ID: O20070926000354 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Modesto Advanced Diagnostic Imaging Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1730133893 PECOS PAC ID: 1850336736 Enrollment ID: O20080313000323 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Santa Rosa Imaging Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689890444 PECOS PAC ID: 2567408859 Enrollment ID: O20100324000598 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Entity Name | Radiant Imaging Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437583200 PECOS PAC ID: 7113145558 Enrollment ID: O20140827001815 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Binh To Tran, MD Po Box 1047, Corvallis, OR 97339-1047 Ph: (888) 752-6151 | Dr Binh To Tran, MD 612 W Duarte Rd, Arcadia, CA 91007 Ph: (626) 821-8124 |
News Archive
Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.
By transducing two genes (c-MYC and BCL-XL) into iPS cells and ES cells, a Kyoto University research team led by Prof. Koji Eto at CiRA has succeeded in producing erythrocyte progenitor cells with almost unlimited ability to replicate in vitro, which they then differentiated successfully into mature erythrocytes. Although these erythrocytes consisted mostly of fetal-type hemoglobin, they were confirmed to have oxygen-carrying capacity and to have circulatory capacity following transfusion into mice.
The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 1,000,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $200,000.00 to the Company.
One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.
Elderly individuals who have a report of self-neglect or abuse submitted to a social service agency have an associated increased risk of death, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
› Verified 4 days ago
Dr. Juan Carlos Echeverria, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 300 W Huntington Dr, Arcadia, CA 91007 Phone: 626-898-8004 Fax: 626-898-8235 | |
Dr. Shengyang Wu, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 W Huntington Dr Ste 120, Arcadia, CA 91007 Phone: 626-574-3657 Fax: 626-898-8016 | |
Mr. Leon Edward Lis, MD Radiology Medicare: Medicare Enrolled Practice Location: 612 W Duarte Rd, Ste 101, Arcadia, CA 91007 Phone: 626-445-4850 Fax: 626-445-0482 | |
Dr. Brian H Lee, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 612 W Duarte Rd Ste 101, Arcadia, CA 91007 Phone: 626-447-0035 | |
Mr. Wilson Shen Wong, MD Radiology Medicare: Medicare Enrolled Practice Location: 300 W Huntington Dr, Arcadia, CA 91007 Phone: 626-898-8610 | |
Thomas Zung, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1630 La Ramada Ave, Arcadia, CA 91006 Phone: 626-447-4477 Fax: 626-355-6962 | |
Mr. Jose Solomon Tandoc, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 612 W Duarte Rd Ste 101, Arcadia Radiology Medical Group, Arcadia, CA 91007 Phone: 626-445-4850 Fax: 626-445-0482 |